INNOVITA obtained qualification for 1 product
I'm PortAI, I can summarize articles.
INNOVITA recently announced that the company has obtained a new product qualification for the Respiratory Syncytial Virus, Adenovirus, Human Metapneumovirus, and Parainfluenza Virus Antigen Combined Detection Kit (Latex Chromatography Method). This product is used for the qualitative detection of multiple viral antigens in oropharyngeal swab samples, and the acquisition of this qualification will broaden the company's product line, enhance market expansion capabilities, and strengthen core competitiveness
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments